Skip to main content
. Author manuscript; available in PMC: 2015 Aug 13.
Published in final edited form as: Cochrane Database Syst Rev. 2014 Aug 13;8:CD003256. doi: 10.1002/14651858.CD003256.pub2

Comparison 9. Liposomal doxorubicin versus conservative management (non-RCT).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality 1 29 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.75, 1.15]